Immix Biopharma, INC. (IMMX) — 8-K Filings

8-K Filings (13)

• 8-K Filing — Mar 30, 2026
• Immix Biopharma Files 8-K on Material Definitive Agreement — Mar 25, 2026
  Immix Biopharma, Inc. filed an 8-K on March 25, 2026, indicating an "Entry into a Material Definitive Agreement" under Item 1.01. While the specific details of
• 8-K Filing — Dec 8, 2025
• Immix Biopharma Files 8-K: Corporate Details Updated — Nov 26, 2025 Risk: low
  Immix Biopharma, Inc. filed an 8-K on November 26, 2025, reporting on other events and financial statements. The filing details the company's principal executiv
• Immix Biopharma Files 8-K: Agreements, Equity Sales, Officer Changes — Sep 8, 2025 Risk: medium
  Immix Biopharma, Inc. filed an 8-K on September 8, 2025, reporting on several key events. These include entering into a material definitive agreement, unregiste
• Immix Biopharma Reports on Shareholder Vote — Jun 23, 2025 Risk: low
  Immix Biopharma, Inc. filed an 8-K on June 23, 2025, reporting on a matter submitted to a vote of its security holders on June 20, 2025. The filing details the
• Immix Biopharma Files 8-K: Material Agreement & Exhibits — Jun 3, 2025 Risk: medium
  On June 3, 2025, Immix Biopharma, Inc. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financial statements
• Immix Biopharma Files 8-K: Corporate Updates — Jul 26, 2024 Risk: low
  Immix Biopharma, Inc. filed an 8-K on July 25, 2024, reporting other events and financial statements. The filing details the company's corporate structure, incl
• Immix Biopharma Changes Certifying Accountant — Jul 22, 2024 Risk: low
  Immix Biopharma, Inc. filed an 8-K on July 22, 2024, reporting a change in its certifying accountant as of July 17, 2024. The company also included financial st
• Immix Biopharma Announces Corporate Changes and Shareholder Votes — Jun 14, 2024 Risk: medium
  Immix Biopharma, Inc. announced on June 11, 2024, a series of significant corporate actions. These include the election of new directors, the appointment of cer
• Immix Biopharma Reports Unregistered Equity Sales — May 20, 2024 Risk: medium
  Immix Biopharma, Inc. filed an 8-K on May 20, 2024, reporting unregistered sales of equity securities. The filing also includes other events and financial state
• IMMX Files 8-K on Material Definitive Agreement; Details Undisclosed — Feb 6, 2024
  Immix Biopharma, Inc. filed an 8-K on February 6, 2024, to report an "Entry into a Material Definitive Agreement" and "Other Events." While the filing indicates
• Immix Biopharma Files 8-K on Feb 5, Confirms Nasdaq Listing — Feb 5, 2024
  Immix Biopharma, Inc. filed an 8-K on February 5, 2024, under the 'Other Events' category, indicating a routine update or disclosure that doesn't fall under spe

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX